Evidence-based medicine for dermatologic surgeons: Concepts in critical appraisal of information

Dermatologic Surgery

Volumn 27, Issue 6, 2001, Pages 511-514

  Berg, Daniel ^a,b   Asgari, Maryam ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL PRACTICE; DECISION MAKING; EVIDENCE BASED MEDICINE; PATIENT CARE; PATIENT INFORMATION; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; SKIN SURGERY; SURGEON;

CLINICAL TRIALS; DERMATOLOGY; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 0034978896     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2001.01022.x     Document Type: Review

References (39)

1. Information excess in medicine. Overview, relevance to dermatology, and strategies for coping
2. Evidence-based medicine: What it is and what it isn't
3. Evidence-based medicine: The epistemology that isn't
4. Welcome to evidence-based medicine
5. How to read a paper. Getting your bearings (deciding what the paper is about)
6. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study
7. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment
8. Users' guides to the medical literature. IX. A method for grading health care recommendations
9. 1999 Canadian recommendations for the management of hypertension
10. Guidelines for the management of basal cell carcinoma
11. In defense of expert opinion
12. Nineteenth-century patent medicines for the skin and hair
13. Did we learn evidence-based medicine in medical school? Some common medical mythology
14. A comparison of pressure patching versus no patching for corneal abrasions due to trauma or foreign body removal
15. Should we patch corneal abrasions? A meta-analysis
16. Did we learn evidence-based medicine in medical school? Some common medical mythology
17. Recessive dystrophic epidermolysis bullosa treated with phenytoin
18. Lack of efficacy of pehnytoin in recessive dystrophic epidermolysis bullosa
19. Oral corticosteroids for pain associated with herpes zoster
20. Treatment of basal cell carcinoma with intralesional interferon
21. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up
22. Intralesional alfo-2a interferon therapy for basal cell carcinoma
23. Use of recombinant interferon alfoa-2b in the treatment of basal cell carcinoma
24. Consideration of the cost of interferon alfa-2b in the treatment of basal cell carcinoma
25. Intralesional interferon-alpha 2b treatment of basal cell carcinoma
26. Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery
27. Safety of silicone breast implants: Scientific validation/vindication at last
28. Epidemiology versus outcome. The silicone breast implant controversy
29. Association of silicone breast implants with immunologic abnormalities: A prospective study
30. Ethics, epidemiology, and law: The case of silicone breast implants
31. Absence of longitudinal changes in rheumatologic parameters after silicone breast implantation: A prospective 13-year study
32. Never underestimate a placebo
33. The placebo effect in animals
34. The powerful placebo effect: Fact or fiction?
35. Expectations and the placebo effect in clincial drug trials: Why we should not turn a blind eye to unblinding and other cautionary notes
36. Finasteride in the treatment of men with androgenetic alopeci
37. Intralesional interferon therapy for basal cell carcinoma
38. Surgery as a placebo